LBCTC
LBCTC
LBCTC
Q1
Note 1
31/3/20x2
Sales of goods=> revenue from sales of goods is recognized for the year ended 31/3/2
Service renderred to customer in two years since 1/4/20x2=> service revenue is recog
Correcting entries
J1: for revenue
Dr Service revenue
Cr Unearned service revenue
J2: for COS
Dr Inventory
Cr COS
Note 2
Property
Cost -1/4/20x1 48,000
Less: Acc dep -1/4/20 -16.000
CA - 1/4/20x1 32,000
Revalued amount 1/4 36,000
Amortization/ deprec 4,500
(36,000/8;14,000*20%)
CA - 31/3/20x2 31,500
J5:depreciation/ amortiation
Dr COS: 4,500+2,800
Cr Acc amortiation-property
Cr acc depreciation-Plant&equip
Note 3
FV of investment property 31/3/20x2
Less FV of IP at 31/3/20x2
Gain on change FV
Note 4 J7
Dr income tax expense
Cr Income tax payable
Statement P,L and other comprehence income
For the year ended 31/3/20x2
Currency unit(CU):$'000
Revenue: 280,800(per Q) -2,080(J1)
Less COGS
280,800(per Q)-1,600(J2)+7,300(J5)
Gross profit
Selling expense
Admin expense
Bank Interest expense
gain on change of FV(J6)
Loss before tax
Less: income tax expense(J7)
Net profit(loss)
Other comprehensive income
Surplus on revaluation(J3)
Total net loss and other comprehensive income
Pressco
Statement of financial position
As at 31/3/20x2
Currency unit (CU):$'000
A/R
Inventory: 25,200(per Q)+1,600(J2)
Property(note 2)
Plant & Equpment (note2)
IP:10,000(perQ)+2,000(J6)
Total assets
Liabilities and OE
Liabilities
Bank overdraft
A/P
unearned service revenue(J1)
income tax payable
Total liabilities
2.080
1,600
Did
Dr Cash 2.080
2.080 Cr Service revenue 2.080
Dr COS 1.600
Cr inventory 1.600
1.600 (+inventory,B/S)
1.600 (-COS,P/L)
11,200
reveluation
4,000 (+property,B/S)
urplus on revaluation 4,000 (+ other comprehensive income, P/L)
preciation/ amortiation
S: 4,500+2,800 7,300
cc amortiation-property 4,500
cc depreciation-Plant&equipment 2,800
12,000
-10,000
2,000
J6:
Dr IP 2,000
Cr Gain on change of FV 2,000
278,720
-275,100
-7,780
-16,100
-26,900
-300
2,000
-49,080
-3,000
-52,080
4,000
-48,080
sco
ancial position
3/20x2
28,500
26,800
31,500
11,200
12,000
110,000
1,400
27,300
2,080
3,000
33,780
RE Revaluation surplus
5,100 -
4,000
500 (500)
(52,080)
(46,480) 3,500
Q2 Items reported on trial balance +/- adjustment
J2: Dr Property
Cr Surplus on revaluation
For investment property
FV at 31/3/20X2 8000
Less: FV at 1/4/20X1 10000
Loss from changes of FV 2000
Should be done
Total expenditure: 40*7 280
Dr Research expense: 40*4 160
Dr Development cost: 40*3 120
Cr Cash, …
J6: Dr Research expense: 40*4 160
Dr Development cost: 40*3 120
Cr COS
Revenue: 280,800(per Q)
Less COS
Gross profit
Selling expense
Admin expense: 26900 (per Q) +6100
Bank Interest expense
Loss on change of FV (J3)
Research expense (J6)
Loss before tax
Less: income tax expense(J7)
Net profit(loss)
Other comprehensive income
Surplus on revaluation(J3)
Total net loss and other comprehensive income
c) Fressco
Statement of financial position
As at 31/3/20x2
Currency unit (CU):$'000
Asset
A/R 28,500
Inventory: 25,200(per Q) - 200 25,000
Property 34,000
Plant & Equpment 11,900
IP:10,000(perQ) - 2,000 8,000
Development cost 120
Total assets 107,520
Liabilities
Bank overdraft 1,400
A/P 27,300
income tax payable 1,500
Total liabilities 30,200
Owners' equity
Equity share 45,000
Share premium 74,200
RE (47,880)
Revaluation surplus 6,000
Total OE 77,320
Total L + OE 107,520
se: 4000 + 2100 6100
6100
6000
revaluation 6000
1500
1500
a-b 200
a-b 200
Treated as expense in their period in which the occur
=> Capitallized into development cost
Did
Dr COS 280
Cr Cash, … 280
280
280
CU: $000
280,800
-280720
80
-16,100
-33,000
-300
-2,000
-160
-51,480
-1,500
-52,980
6,000
-46,980
J2 Dr COS 29063
Cr Acc dep 29063
- Property 2000
- P&E 27063
For note iv
J3 Dr Income tax expense 28000
Cr Acc dep 28000
For note ii
Carying amount (up to date) 65000 CA = RA => No impairment loss
Recoverable amount 77313 CA < RA => No impairment loss
The higher of net FV or value in use CA > RA => Impairment loss = CA - RA
Net FV: 78000-2500 75500
Value in use: 77313
30000/1.08 + 30000/1.08^2 + 30000/1.08^3
=> As RA = 77313 > CA = 65000 => No impairment loss => No need for adjustment
For note v
Dr Bad debt expense 15
Cr A/R 15
15000
15000
Non-current asset
Property 22,000
PPE 189,438
Total asset 265,123
Liabilities
Bank 1,400
Trade payable 30,300
Income tax payable 28,000
Total Liabilities 59,700
Owner's Equity
Equity share 40,000
Share premium 5,000
Retained earning 160,422
Total equity 205,422
S - investee
100*60% = 60 30% non controlling interest (NCI)
S1 40% NCI
Dividend : 100
Voting right of P in S1 = 70% > 50%
=> S1 is also a subsidiary of P
Other conditions:
- P is a major customer of S
- P is a major supplier of S
P - investor Individual FSs of P - 4/5 board of director is representative of P
…
S - investee
Warehouse # 1
S - investee
Individual FSs of S Warehouse # 1
Consolidated FSs
Different = Acquisition + Fair value of NCI - Fair value of identifiable net assets of S (FVINA)
If Different > 0 => Different called positive goodwill (goodwill)
If Different < 0 => Different called negative goodwill (bargain on purchase)
Q1.
a) Acquisition analysis
Acquisition costs $'000
Cash paid 92000
Defered payment: 28000/(1+8% 24005
116005
FV of NCI 15000 Available
131005
Less: FVINA Book value= Identifiable net asset = OE
Equity share 60000 = Total assets - Total liabilities
RE (1/10/20X4) 34000
Revaluation surplus 4000
FV > BV of inventory 600
(3600-3000)
98600
Goodwill: 131005 - 98600 32405
Sold to S $13/unit
P S
P S
Case 1: 100 units of inventory were sold by S to outsider, selling price/unit: $15
P S Line By LineEliminationConsolidated results
Sale reven 1300 1500 2800 -1300 1500
COS 1000 1300 2300 -1300 1000
300 200 500
W2 Ending URP
Group profit % = (Revenue - COS)/Revenue * 100%
25% = (8000 - COS)/8000
=> COS = 8000 - 25%*80000 = 75% * 8000 6000
Total intra group: 8000 - 6000 2000
=> End URP: 2000*1/ 250
If P is seller => downstream transactions
+ 100% URP must be eliminated
+ 100% URP attributable to only P
If P is purchaser => upstream transactions
+ 100% URP must be eliminated
+ URP attributable to both Parent and NCI
W4 Consolidated RE
RE of P 210000
Add: RE of S increased 2000
(36500 - 34000)*80%
Less: End URP (downs -250
Less: Interest on def -1920
(24005*8%)
Consolidated RE 209830
W5 NCI 15000
NCI at acquisition date 5000
Add: RE of S incresed post to acquit
(36500-34000)*20% 15500
NCI at 30/09/20X5
Equity
-Equity shares: 190000 + 60000 - 60000 190000
-RE (W4) 209830
-Surplus on revaluation: 41400
441230
-NCI (W5) 15500
Total equity 456730
Liabilities
NC liability
Deferred consideration: 116005 + 1920(W4) 117925
Current liability: 45300 + 28150 73450
Total liability 191375
Total OE + L 648105
Q3.
1/4/2015==================> 1/10/2015================>31/3/2016
W1 Acquisition analysis
Goodwill = Acquisition cost + FV of NCI - FVINA
Goodwill at reporting date = Goodwill at acquisiton - Acc. Impairments
Acquisition cost
- Number of acquired shares: 9000*60% 5400
- Number of exchanged shares 2700
- Fair value of exchange shares: 3*2700 8100
-PV of deferred payment: 0.54*5400/(1+8%)^1 2700
10800
FV of NCI: 9000*40%*1.5 5400
16200
Less: FVINA
- Equity share 9000
- Open bal of RE 8600
- Loss accrual from 1/4/2015 to 1/10/2015 -1500
(3000/12*6)
- FV<BV of plant -2500 13600
Goodwill at acquisition: 16200-13600 2600
Less: Accumulative impairment loss 0
Goodwill at reporting date (31/3/2016) 2600
W2 Consolidated PPE BV
FV (consolidated)
Useful
S Consolidation
Dep. Expen 2000 1500
Dep. Expense
PPE of P 25400
Add: PPE of S 13500
Less: FV<BV -2500
Add: Diff in dep. Expense as FV<BV 500
Consolidated PPE 36900
W4 Inventory
Downstream sale transactions => Total URP attributable to only P
Selling price = COS + COS*35% = COS*135%
2430 = COS*135%
=> COS = 2430/135% = 1800
Ending URP: 2430-1800 630
Inventory of P 12700
Add: Inventory of S 5300
Less: Ending URP -630
Consolidated inventory 17370
W5 Consolidated RE
RE of P
Less: Lost post to acquisition attributable to P
(-3000/12*6*60%)
Less: URP downstream
Add: Diff in dep as FV<BV
(500*60%)
Less: Interest on deferred payment
(2700*8%/12*6)
Add: FV>BV
W6 NCI
P - investor
100*70%=30%
interest (NCI)
benefit of P in S1 = 70%*60%=42%
or is representative of P
Warehouse # 1 Warehouse # 2
Warehouse # 1 Warehouse # 2
External
Dr Investment in S 20000
Cr Cash 20000
Zanda Medda
1 => 2
2700 <= 5400
Months
Difference
500
Q3 - Review
a) Goodwill on acquisition = Acquisition cost + FV of NCI - FVINA
Acquisition cost
FV of exchange shares
+ Number of shares acquired: 100000*90% 90000
+ Number of new shares issued: 2*90/3 60000
+ FV of new shares issued: 6.5*60000 390000
Present value of deferred payment: 90000*1.76/(1+10%)61 144000
534000
FV of NCI
+Number of shares held by NCI: 100000*10% 10000
+FV/share 2.5
+FV of NCI 25000
559000
Less: FVINA
Share capital 100000
RE 1/10/20x1 350000
Add: Net profit accrual from 1/10/20x1 => 1/1/20x2 16500
66000/12*3
Fv > BV of plant 1800 468300
Goodwill at acuisition date 90700
Less: Impairment of goodwill -20000
Goodwill at reporting date 88700
b) Consolidated revenue = Revenue of P + Revenue of S post to acquisiton - Inter group sales (post acquisition)
Revenue of P
Add: Revenue of S post to acquisition
240000/12*9 18000
Less: Intra group sales 800*9 7200
Consolidated revenue 622800
e) Consolidated finance costs = Finance cost of P + Finance cost of S post to acquisition +(-) other adjustments
Finance cost of P 1500
Add: Finance cost of S post to acquisition 900
1200/12*9
Add: Interest expense on defered payment 10800
144000*10%/12*9
Consolidated finance cost 13200
g) Consolidated net profit = Consolidated income (sale revenue) - Consolidated expense (COGS,admin,…)
Consolidated revenue 622800 (b)
Less: Consolidated COS 366050 (c)
286750
Less:
- Distribution cost: 23600+12.000/12*9 32600
- Admin expense 44250 (d)
- Finance cost 13200 e
- Impairment loss of goodwill 2000
Q4
a) Goodwill on acquisition = Acquisition cost + FV of NCI - FVINA
Acquisition cost
FV of exchange shares
+ Number of shares acquired: 7200
+ Number of new shares issued: 4800
+ FV of new shares issued: 14400
Present value of deferred payment: 10080
24480
FV of NCI
+Number of shares held by NCI: 100000*10% 900
+FV/share 2.5
+FV of NCI 2250
Acquisition cost 26730
Less: FVINA
Share capital 9000
RE 1/10/20x1 3500
Add: Net profit accrual from 1/10/20x1 => 1/1/20x2 4950
Fv > BV of plant 720 18170
Goodwill at acuisition date 8560
Less: Impairment of goodwill -500
Goodwill at reporting date 8060
b) Consolidated revenue = Revenue of P + Revenue of S post to acquisiton - Inter group sales (post acquisition)
Revenue of P 45000
Add: Revenue of S post to acquisition 18000
Less: Inter group sales: 420*9 -3780
Consolidated revenue 59220
Viagren Graca
2===============> 3
? <============== 90000
Available
= Number of shares held by NCI * FV of share/unit
es (post acquisition)
) other adjustments
OGS,admin,…)
es (post acquisition)
Q2
1/4/204 ================> 1/7/2014 ================> 31/3/2015
Acquisition date
3 months 9 months
b) Line by line
Revenue & expense
Revenue, expense for parent: whole
Revenue, expense for subsidiary: post to acquisition
(i) Consolidates revenue
Revenue of Bycomb 24,200
Add: Revenue of Cyclip post to acquisition 8,100
Less: Intra sale (3,000)
Consolidated revenue 29,300
(ii) Consolidated COS = COS of P + COS of S post to acquisition - Intra group - End URP +/- other adjustments
Ending unrealized profit COS of P
Selling price = COS + COS*20% = COS*1.2 => COS = Selling price/1.2 Add: COS of S
Selling price 420 Less: Intra group sale
COS 350 Add: End URP
End URP: 70 Add: Excess of Dep expense as FV>BV
Add: Impairment loss of goodwill
Consolidated COS
iii) Consolidated finance costs = Finance cost of P + Finance cost of S post at acquisition +/- other adjustments
Finance cost of P 400
Add: Finance of S post to acquisition 225
Add: Interest expense on deferred payment 1,008
Consolidated finance costs 1,633
iv) Net profit attributable to NCI = Net profit of S post to acquisition from consolidation attributable to NCI
= Net profit of S post to acquisition from consolidation attributable to NCI
Net profit of S post at acquisition attributable to NCI 360
Less: Impairment of Goodwill: 500*20% (100)
Less: excess of dep expense as FV > BV of plant (72)
Net profit attributable to NCI 188
other adjustments
17,800
5,100
a group sale (3,000)
70
ss of Dep expense as FV>BV 360
airment loss of goodwill 500
20,830